BCMA-CD19 cCAR-T for the Treatment of Refractory Inflammatory Myopathy

NCT07715136 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Inflammatory Myopathy

Interventions

BIOLOGICAL: ICG318, BCMA-CD19-IL-15/IL-15 sushi Compound CAR-T

Sponsor

iCell Gene Therapeutics